| Code | CSB-RA015761A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| IP | 1:200-1:1000 |
NFKBIA, also known as IκB-alpha, serves as a critical regulator of the NF-κB signaling pathway by sequestering NF-κB transcription factors in the cytoplasm and preventing their nuclear translocation. This inhibitory function makes NFKBIA a central focus in research exploring inflammatory responses, immune regulation, and cancer biology, where dysregulated NF-κB signaling frequently contributes to disease progression.
This recombinant monoclonal antibody, developed using rabbit host cells and clone 1E9, offers the reproducibility and consistency that demanding experimental workflows require. Because the antibody sequence is defined and production occurs through recombinant expression, researchers benefit from lot-to-lot uniformity that traditional hybridoma-derived antibodies cannot guarantee. This reliability proves especially valuable for longitudinal studies or when establishing standardized protocols across research teams.
Validation testing demonstrates robust performance across multiple applications. Western blot analysis confirms specific detection of NFKBIA at the expected 36 kDa molecular weight across a diverse panel of human cell lines, including HeLa, HepG2, Jurkat, Raji, PC3, and THP-1 lysates, providing confidence when working with various cellular models. The antibody has also been validated for immunohistochemistry in paraffin-embedded human endometrial cancer tissue, enabling researchers to examine NFKBIA expression patterns within intact tissue architecture. Additionally, immunoprecipitation studies in HepG2 lysates confirm the antibody's utility for protein interaction studies and enrichment applications.
The affinity-purified formulation arrives ready for use across ELISA, western blotting, immunohistochemistry, and immunoprecipitation workflows. For investigators studying signal transduction mechanisms, inflammatory pathways, or NF-κB-dependent processes in cancer and immunity, this antibody provides a dependable tool for characterizing NFKBIA expression and regulation.
Applications : Western blotting
Sample type: cells
Review: The protein (total p65/IκB-α and phosphorylated p65/IκB-α) levels were measured via western blot assay after myrislignan treatment in U87 and U251 cells.
By Anonymous